This agreement is the first of its kind between a Canadian cannabis company and a world leader in Health Science services and sets out to develop a "Centre of Excellence in Plant Based Medicine Analytics".
The future of drug control treaties is in doubt due to recent treaty-violating decisions to legalize cannabis in several countries.
Despite 29 states legalizing marijuana for medicinal use, few medical students are being trained to prescribe the drug.
After an observation autism trial in Chile, results revealed successful treatment for autism using medical marijuana extracts.
The act has been reintroduced to remove regulatory barriers that inhibit researchers from obtaining marijuana plans to conduct studies on medical effectiveness and safety.
Evidence from neurobiological research points to cannabinoids as possible therapeutic agents of interest for PTSD, a condition that over 3.5 million people suffer with in the USA alone.
With the right partners and preparations, any cannabis company can get professional analysis.
Western University researchers have found a way to use pharmaceuticals to reverse the negative psychiatric effects of THC.